Total Valuation
Dexcom has a market cap or net worth of $576.57B. The enterprise value is $32.67B.
Market Cap$576.57B
Enterprise Value$32.67B
Share Statistics
Dexcom has 377,360,780 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding377,360,780
Owned by Insiders0.41%
Owned by Institutions2.70%
Financial Efficiency
Dexcom’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 16.61%.
Return on Equity (ROE)0.30
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)16.61%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee421.90K
Profits Per Employee75.68K
Employee Count11,050
Asset Turnover0.74
Inventory Turnover2.96
Valuation Ratios
The current PE Ratio of Dexcom is 31.8. Dexcom’s PEG ratio is 0.67.
PE Ratio31.8
PS Ratio5.56
PB Ratio9.43
Price to FCF24.04
Price to Operating Cash Flow21.80
PEG Ratio0.67
Income Statement
In the last 12 months, Dexcom had revenue of 4.66B and earned 836.30M in profits. Earnings per share was 2.14.
Revenue4.66B
Gross Profit2.80B
Operating Income911.80M
Pretax Income1.09B
Net Income836.30M
EBITDA1.36B
Earnings Per Share (EPS)2.14
Cash Flow
In the last 12 months, operating cash flow was 1.41B and capital expenditures -316.10M, giving a free cash flow of 1.10B billion.
Operating Cash Flow1.41B
Free Cash Flow1.10B
Free Cash Flow per Share2.91
Dividends & Yields
Dexcom pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.39
52-Week Price Change31.41%
50-Day Moving Average1.54K
200-Day Moving Average1.32K
Relative Strength Index (RSI)29.68
Average Volume (3m)59.00
Important Dates
Dexcom upcoming earnings date is Feb 11, 2027, After Close (Confirmed).
Last Earnings DateOct 29, 2026
Next Earnings DateFeb 11, 2027
Ex-Dividend Date―
Financial Position
Dexcom as a current ratio of 1.88, with Debt / Equity ratio of 54.94%
Current Ratio1.88
Quick Ratio1.59
Debt to Market Cap0.05
Net Debt to EBITDA0.35
Interest Coverage Ratio49.83
Taxes
In the past 12 months, Dexcom has paid 252.10M in taxes.
Income Tax252.10M
Effective Tax Rate0.23
Enterprise Valuation
Dexcom EV to EBITDA ratio is 19.41, with an EV/FCF ratio of 24.48.
EV to Sales5.66
EV to EBITDA19.41
EV to Free Cash Flow24.48
EV to Operating Cash Flow18.30
Balance Sheet
Dexcom has $1.82B in cash and marketable securities with $1.39B in debt, giving a net cash position of $425.00M billion.
Cash & Marketable Securities$1.82B
Total Debt$1.39B
Net Cash$425.00M
Net Cash Per Share$1.13
Tangible Book Value Per Share$6.79
Margins
Gross margin is 63.42%, with operating margin of 19.56%, and net profit margin of 17.94%.
Gross Margin63.42%
Operating Margin19.56%
Pretax Margin23.35%
Net Profit Margin17.94%
EBITDA Margin29.14%
EBIT Margin23.74%
Analyst Forecast
The average price target for Dexcom is $1,868.22, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$1,868.22
Price Target Upside22.19% Upside
Analyst ConsensusStrong Buy
Analyst Count18
Revenue Growth Forecast1.48%
EPS Growth Forecast27.91%